Program
Tin Fluorides
Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.
Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.
Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmoliveits history only | 182 open or running | phase 4since Feb 6, 2015 | Sep 26, 2008 | Sep 2027phase 4 · NCT07807397 |
| Procter and Gambleits history only | 142 open or running | phase 4since Aug 28, 2025 | Feb 28, 2012 | none ahead |
| GlaxoSmithKlineits history only | 80 open or running | phase 3since May 3, 2012 | May 3, 2012 | none ahead |
| HALEONits history only | 40 open or running | no phasesince Nov 16, 2023 | Nov 16, 2023 | none ahead |
| Church & Dwightits history only | 30 open or running | no phasesince Feb 12, 2026 | Feb 12, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 31 studies since Sep 26, 2008.
- Oct 23, 2024No phase study in Gingival DiseasesProcter and Gamble · NCT06659471 · 120 enrolled · United States
- Oct 24, 2024No phase study in Dental PlaqueHALEON · NCT06660069 · 199 enrolled · United States
- Apr 30, 2025Phase 1 study in GingivitisProcter and Gamble · NCT06962956 · 135 enrolled · United States
- Aug 28, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07158112 · 120 enrolled · United States
- Sep 29, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07211061 · 69 enrolled · United States
- Oct 29, 20252 phase 3 studiesColgate Palmolive · NCT07223073, NCT07223060
- Jan 27, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07398846 · 134 enrolled · United States
- Feb 12, 2026Church & Dwight’s first studies: 2 no phase studiesNew to Church & DwightChurch & Dwight · NCT07419737, NCT07425509
- Mar 4, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07458464 · 95 enrolled · Thailand
- May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729 · 10,000 planned · United States
- Jun 2, 2026No phase study in GingivitisChurch & Dwight · NCT07640399 · 133 enrolled · Canada
- Jul 26, 2026Phase 3 study in Dental HypersensitivityColgate Palmolive · NCT07738198 · 116 enrolled · United States
- Sep 2, 2026Phase 4 study in Periodontal DiseasesColgate Palmolive · NCT07807397 · 500 planned
- Oct 29, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07917507 · 84 enrolled · Dominican Republic
Ahead
- Sep 2027Primary completion: phase 4 study in Periodontal DiseasesColgate Palmolive · NCT07807397
- Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 47 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07917507Plaque, Amyloid · Dominican Republic | 3 | Completed | Colgate Palmolive | Nov 4, 2026 | 84 |
| NCT07807397Periodontal Diseases | 4 | Not yet recruiting | Colgate Palmolive | Sep 2027 | 500 |
| NCT07738198Dental Hypersensitivity · United States | 3 | Completed | Colgate Palmolive | Dec 8, 2018 | 116 |
| NCT07640399Gingivitis · Canada | – | Completed | Church & Dwight | Jun 13, 2025 | 133 |
| NCT07619729Diabetes Mellitus, Type 2 · United States | 4 | By invitation | Colgate Palmolive | Jan 2, 2028 | 10,000 |
| NCT07458464Plaque, Amyloid · Thailand | 3 | Completed | Colgate Palmolive | Jun 28, 2026 | 95 |
| NCT07425509Halitosis · United States | – | Completed | Church & Dwight | Nov 4, 2024 | 49 |
| NCT07419737Dental Plaque · United States | – | Completed | Church & Dwight | Dec 4, 2024 | 91 |
| NCT07398846Plaque, Amyloid · United States | 3 | Completed | Colgate Palmolive | Apr 29, 2026 | 134 |
| NCT07223073Oral Malodor · Thailand | 3 | Completed | Colgate Palmolive | Jan 12, 2018 | 80 |
| NCT07223060Dental Calculus · Thailand | 3 | Completed | Colgate Palmolive | Oct 6, 2017 | 100 |
| NCT07211061Gingivitis · United States | 4 | Completed | Procter and Gamble | Nov 10, 2011 | 69 |
| NCT07158112Gingivitis · United States | 4 | Active, not recruiting | Procter and Gamble | Dec 7, 2025 | 120 |
| NCT06962956Gingivitis · United States | 1 | Active, not recruiting | Procter and Gamble | Oct 31, 2025 | 135 |
| NCT06660069Dental Plaque · United States | – | Completed | HALEON | Mar 11, 2025 | 199 |
| NCT06659471Gingival Diseases · United States | – | Completed | Procter and Gamble | Jun 6, 2022 | 120 |
| NCT06427499Plaque, Amyloid · Thailand | 3 | Completed | Colgate Palmolive | Aug 5, 2024 | 95 |
| NCT06354270Dentin Sensitivity · United States | – | Completed | HALEON | Jun 23, 2024 | 115 |
| NCT06359028Dentin Sensitivity · United States | – | Completed | HALEON | Jun 20, 2024 | 111 |
| NCT06353165Dental Plaque · Thailand | 3 | Completed | Colgate Palmolive | Apr 12, 2023 | 100 |
| NCT06242769Tooth Stain Removal · Puerto Rico | 3 | Completed | Colgate Palmolive | Sep 14, 2020 | 80 |
| NCT06143670Gingivitis · United States | – | Completed | HALEON | Mar 12, 2024 | 159 |
| NCT06140784Gingivitis · United States | – | Completed | Procter and Gamble | Dec 10, 2023 | 116 |
| NCT06140771Gingivitis · United States | – | Completed | Procter and Gamble | Feb 6, 2022 | 115 |
| NCT06140758Caries · Australia | – | Completed | Procter and Gamble | Dec 11, 2023 | 12 |
| NCT05326373Gingivitis · United States | – | Completed | Procter and Gamble | Jun 13, 2022 | 40 |
| NCT04123665Gingivitis · United States | 3 | Completed | GlaxoSmithKline | Dec 11, 2013 | 98 |
| NCT05731778Gingivitis · Canada | 4 | Completed | Colgate Palmolive | Dec 22, 2020 | 26 |
| NCT04033575Gingivitis · United States | 4 | Completed | Colgate Palmolive | Jun 6, 2019 | 88 |
| NCT03852056Dental Plaque · China | 3 | Completed | Colgate Palmolive | Dec 7, 2017 | 98 |
| NCT03296657Subgingival Plaque · United States | – | Completed | Procter and Gamble | Sep 22, 2017 | 20 |
| NCT03072719Dentin Sensitivity · Ireland | 3 | Completed | GlaxoSmithKline | Jun 1, 2012 | 120 |
| NCT02841839Subgingival Plaque | – | Completed | Procter and Gamble | Jun 2016 | 20 |
| NCT02752958Dentin Sensitivity · United Kingdom | – | Completed | GlaxoSmithKline | Feb 1, 2017 | 75 |
| NCT02832375Dentin Sensitivity · United States | 3 | Completed | GlaxoSmithKline | May 1, 2016 | 242 |
| NCT02613130Oral Malodor · United States | – | Completed | Procter and Gamble | Dec 2015 | 60 |
| NCT02750943Gingivitis · United States | – | Completed | GlaxoSmithKline | Mar 1, 2016 | 253 |
| NCT02574221Plaque, Amyloid · United States | – | Completed | Procter and Gamble | Oct 2015 | 60 |
| NCT02543060Plaque, Amyloid · United States | – | Completed | Procter and Gamble | Aug 2015 | 60 |
| NCT02366689Dental Plaque · United States | 4 | Completed | Colgate Palmolive | Dec 2014 | 179 |
| NCT02360995Dental Plaque · United States | 4 | Completed | Colgate Palmolive | Aug 2014 | 129 |
| NCT02193165Dental Plaque · Puerto Rico | 3 | Completed | Colgate Palmolive | Aug 2014 | 120 |
| NCT01827670Dentin Sensitivity · United States | 3 | Completed | GlaxoSmithKline | May 2013 | 119 |
| NCT01592864Dentin Sensitivity · United States | 3 | Completed | GlaxoSmithKline | May 2012 | 120 |
| NCT01592851Dentin Sensitivity · United States | 3 | Completed | GlaxoSmithKline | May 2012 | 113 |
| NCT01549587Gingivitis · United States | – | Completed | Procter and Gamble | Feb 2014 | 746 |
| NCT00762177Oral Bacteria · United States | 3 | Completed | Colgate Palmolive | Sep 2008 | 24 |
How it is read
Names in the registry
- “0.454% Stannous Fluoride Dentifrice”, 8 entries
- “Stannous fluoride toothpaste”, 7 entries
- “Stannous Fluoride”, 6 entries
- “stannous fluoride toothpaste”, 5 entries
- “Stannous Fluoride Toothpaste (SnF)”, 5 entries
Conditions, from the studies’ own filings
- Gingivitis, 20 studies
- Dentin Sensitivity, 8 studies
- Dental Plaque, 7 studies
- Diabetes Mellitus, Type 2, 1 study
- Halitosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.